Moreover, the DIGAMI-2 study10 – attempting to optimise glycaemic control in diabetes patients with myocardial infarction – unexpectedly observed a numerically higher mortality rate in intervention groups, particularly in insulin-treated patients, suggesting a detrimental effect of hypoglycaemia when attempting tighter glucose control. This evidence concerns the gene INS and myocardial infarction.